TY - JOUR. T1 - Outcomes following surgical treatment compared to radiation for stage I NSCLC. T2 - A SEER database analysis. AU - Monirul Islam, K. M.. AU - Shostrom, Valerie. AU - Kessinger, Anne. AU - Ganti, Apar Kishor P. PY - 2013/10/1. Y1 - 2013/10/1. N2 - Introduction: Outcomes following surgery are better than following radiation therapy (RT), for stage I NSCLC. Whether this is due to selection of healthier patients for surgery is unclear. This study was undertaken to compare outcomes between surgical patients and patients who were surgical candidates but did not receive surgery. Methods: Data of patients with stage I NSCLC between 1988 and 2007, included in the SEER database were analyzed. Overall survival (OS) was examined by treatment type (surgery only, radiation only, surgery and radiation, and no treatment). OS was compared between RT patients who refused surgery and those not fit for surgery. Cox proportional hazards model was used to compare outcomes by treatment type. Results: ...
The National Cancer Institutes Surveillance, Epidemiology, and End Results (SEER) program The SEER program, a continuing project of the National Cancer Institute, collects cancer data on a routine basis from designated population-based cancer registries in various areas of the country. Trends in cancer incidence, mortality and patient survival in the United States, as well as many other studies, are derived from this data bank.. Goals of the SEER program are:. , Assembling and reporting, on a periodic basis, estimates of cancer incidence and mortality in the United States. , Monitoring annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. , Providing continuing information on changes over time in the extent of disease at diagnosis, trends in therapy, and associated changes in patient survival. , Promoting studies designed to identify factors amenable to cancer ...
The National Cancer Institutes Surveillance, Epidemiology, and End Results (SEER) program The SEER program, a continuing project of the National Cancer Institute, collects cancer data on a routine basis from designated population-based cancer registries in various areas of the country. Trends in cancer incidence, mortality and patient survival in the United States, as well as many other studies, are derived from this data bank.. Goals of the SEER program are:. , Assembling and reporting, on a periodic basis, estimates of cancer incidence and mortality in the United States. , Monitoring annual cancer incidence trends to identify unusual changes in specific forms of cancer occurring in population subgroups defined by geographic, demographic, and social characteristics. , Providing continuing information on changes over time in the extent of disease at diagnosis, trends in therapy, and associated changes in patient survival. , Promoting studies designed to identify factors amenable to cancer ...
Lang, J. E., Summers, D. E., Cui, H., Carey, J. N., Viscusi, R. K., Hurst, C. A., Waer, A. L., Ley, M. L. B., Sener, S. F. and Vijayasekaran, A. (2013), Trends in post-mastectomy reconstruction: A SEER database analysis. J. Surg. Oncol., 108: 163-168. doi: 10.1002/jso.23365 ...
Findings identify an effective alternative to traditional treatment methods. Research published in Februarys edition of the Journal of Thoracic Oncology investigates the utilization of surgery and the subsequent need for radiotherapy (RT) when treating stage I small cell lung cancer (SCLC). Traditionally, SCLC treatment regimes include chemotherapy and radiotherapy for limited stage disease; however, the study concludes that in selected patients with early stage disease a lobectomy (removal of lung) had an excellent overall survival without additional treatment.. Researchers retrospectively evaluated the outcomes of 247 stage I SCLC patients who underwent lobectomies; these cases were identified using the National Cancer Institutes Surveillance Epidemiology and End Results (SEER) database. Results showed the three- and five-year survival rates for the patient group who underwent lobectomies without RT were 58.1 percent and 50.3 percent, respectively. For those who supplemented their surgery ...
TY - JOUR. T1 - Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery. T2 - Understanding the volume-outcome relationship. AU - Billingsley, Kevin. AU - Morris, Arden M.. AU - Dominitz, Jason A.. AU - Matthews, Barbara. AU - Dobie, Sharon. AU - Barlow, William. AU - Wright, George E.. AU - Baldwin, Laura Mae. PY - 2007. Y1 - 2007. N2 - Hypothesis: Although numerous studies have demonstrated an association between surgical volume and improved outcome in cancer surgery, the specific structures and mechanisms of care that are associated with volume and lead to improved outcomes remain poorly defined. We hypothesize that there are modifiable surgeon and hospital characteristics that explain observed volume-outcome relationships. Design: Retrospective cohort study. Setting: Surveillance, Epidemiology, and End Results cancer registry areas. Patients: Patients aged 66 years and older, diagnosed and surgically treated for stage I, II, or III colon ...
Low-dose interleukin-2 and retinoic acid give unexpected 5-year survival rates for patients with advanced cancers. In a clinical trial of 500 patients with different types of stage 4 solid tumors who had responded to chemotherapy, a maintenance regimen with low-dose interleukin-2 (IL-2) and 13-cis retinoic acid (RA) has shown unexpected 5-year survival rates.. Francesco Recchia, MD, director of oncology at the Civilian Hospital in Avezzano, Italy, is scheduled to present findings from this extended phase II study in a presentation at the American Association for Cancer Research Annual Meeting 2012 in Chicago on April 2.. The open, nonrandomized trial showed substantial improvements for these patients with metastatic cancer compared with corresponding U.S. National Cancer Institute Surveillance Epidemiology and End Results (SEER) data for 5-year overall survival (OS) rates. The OS rate was 42.7% for patients in the study versus 23.3% for breast cancer patients accounted for in SEER data, and ...
The survival statistics come from the National Cancer Institutes Surveillance, Epidemiology, and End Results (SEER) database, and are based on patients who were diagnosed with esophageal cancer between 1999 and 2005.
ACPE UAN #: 0233-0000-17-003-H04-P Release Date: May 27, 2017. Expiration Date: May 27, 2020. Activity Type: Knowledge-based Credit Hours: 0.5 contact hours Activity Fee: Member: $15.00 Non-Member: $30.00 Activity Overview: What becomes possible when you link epidemiologic data to health insurance claims data? Thats one of the many innovative questions being explored at the Hutchinson Institute for Cancer Outcomes Research (HICOR). The HICOR IQ oncology informatics platform integrates cancer registry data (from the Cancer Surveillance System, part of the National Cancer Institute Surveillance, Epidemiology, and End Results [SEER] program) and enrollment and claims data from two large regional commercial insurers that cover more than 2.5 million lives. The goal is to enable performance reporting in oncology as a first step in guiding improvements that increase value in cancer care. This session will provide an overview of HICOR IQ and the related HICOR initiatives focused on promoting ...
TY - JOUR. T1 - Risk of colorectal cancer among long-term cervical cancer survivors. AU - Rodriguez, Ana. AU - Kuo, Yong Fang. AU - Goodwin, James. PY - 2014/5/1. Y1 - 2014/5/1. N2 - Because advances in therapy have increased long-term survival for women with cervical cancer, it is important to study the risk of secondary primary malignancies in high-dose organ areas. From the 1973-2009 National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, we studied the risk of developing cancer of the colon and rectum in 64,507 cervical cancer patients over 35 years after initial radiation treatment. We also assessed change in risk over time. Kaplan-Meier estimator for survival curve and Cox proportional hazards models was used. More than half (52.6%) of the cervical cancer patients received radiation treatment. In the analyses adjusted for race/ethnicity, age, marital status, surgery status, stage and grade, the risk of colon cancer between those both with and without XRT ...
The Incidence of Breast Cancer in the United States The National Cancer Institutes Surveillance Epidemiology and End Results Website reports that the incidence
Site-specific stage adjustments for 1973-2003 SEER Research Data (November 2005 submission). Links to stage adjustments for other data releases, plus summary staging guidance.
The lifetime risks of developing and dying from certain cancers for men and women according to the US National Cancer Institutes Surveillance Epidemiology
Authors: Polite BN, Lamont EB. Title: Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries.. Journal: Cancer 106(4):923-30. Date: 2006 Feb 15. Abstract: BACKGROUND: Multiple epidemiologic studies have reported associations between venous thromboembolic events and subsequent cancer diagnoses, but the published results have not suggested clear cancer screening approaches. METHODS: Using data from the National Cancer Institutes Surveillance, Epidemiology, and End Results-Medicare Program, the authors identified patients who were diagnosed with breast and colorectal carcinoma (n = 7166 patients) and compared them with a noncancer control group (n = 126,668 patients) according to their history of hospitalization for deep vein thrombosis (DVT) or pulmonary embolism (PE) in Medicare claims files over the previous 24 months. Using logistic regression analysis, the authors calculated the odds ...
Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.. All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. ...
This chapter presents current estimates for cancer incidence, mortality, and survival in a large subgroup of the U.S. population based on the results of the Surveillance, Epidemiology, and End Results (SEER) Program. The SEER Program is an ongoing contract-supported program of the National Cancer Institute (NCI) that funds and coordinates the collection of cancer data in population-based cancer registries located throughout the United States. These registries, although not randomly selected, are thought to be reasonably representative of the U.S. population; a number of the registries cover diverse populations of particular epidemiologic interest. The program publishes incidence, mortality, and survival data annually. ...
Many five-year survival rates increased among both blacks and whites, but racial disparities have increased in prostate cancer and female breast cancer. "We still have a lot of work to do to understand the causes of these differences, but certainly differences in the kinds and timing of recommended treatments are likely to play a role," said Dr. Lynne Penberthy, associate director of the U.S. National Cancer Institutes Surveillance Research Program ...
Many five-year survival rates increased among both blacks and whites, but racial disparities have increased in prostate cancer and female breast cancer. "We still have a lot of work to do to understand the causes of these differences, but certainly differences in the kinds and timing of recommended treatments are likely to play a role," said Dr. Lynne Penberthy, associate director of the U.S. National Cancer Institutes Surveillance Research Program ...
Many five-year survival rates increased among both blacks and whites, but racial disparities have increased in prostate cancer and female breast cancer. "We still have a lot of work to do to understand the causes of these differences, but certainly differences in the kinds and timing of recommended treatments are likely to play a role," said Dr. Lynne Penberthy, associate director of the U.S. National Cancer Institutes Surveillance Research Program ...
Men with prostate cancer treated with external beam radiation have a 70% higher risk of developing rectal cancer than men who have surgery, a US study has found. Radiation is now used for about 17% of patients with prostate cancer.. The retrospective population based study used data from the US National Cancer Institutes surveillance, epidemiology, and end results (SEER) register, from 1973 to 1994, and included more than 85 000 men aged 18 to 80. The participants had had invasive microscopically confirmed prostate cancer but no evidence of … ...
Background: Cancers are heterogeneous, comprising distinct tumor subtypes. Therefore, presenting the burden of cancer in the population and trends over time by these tumor subtypes is important to identify patterns and differences in the occurrence of these subtypes, especially to generalize findings to the U.S. general population.. Methods: Using SEER Cancer Registry Data, we present incidence rates according to subtypes for diagnosis years (1992-2013) among men and women for five major cancer sites: breast (female only), esophagus, kidney and renal pelvis, lung and bronchus, and thyroid. We also describe estimates of 5-year relative survival according to subtypes and diagnosis year (1992-2008). We used Joinpoint models to identify years when incidence rate trends changed slope. Finally, recent 5-year age-adjusted incidence rates (2009-2013) are presented for each subtype by race and age.. Results: Hormone receptor-positive and HER2-negative was the most common subtype (about 74%) of breast ...
A premier source for United States cancer statistics, SEER gathers information related to incidence, prevalence, and survival from specific geographic areas that represent 28 percent of the population, as well as compiles related reports and reports on the national cancer mortality rates. Their aim is to provide information related to cancer statistics and decrease the burden of cancer in the national population. SEER has been collecting data from cancer cases since 1973 ...
A system and method that includes providing a query platform with a normalized query tool and a collection interface presenting result items of a collection; adding result items produced by the query tool to a collection, wherein adding a result item to the collection comprising: receiving a query input in a query syntax normalized across multiple query services, retrieving result data of the first query input through a service provider application programming interface (API), processing the result data into result data with at least one context parameter, rendering the result data into a result item, and adding the result item to the collection; and adding at least a second result item to the collection, wherein the second result card is retrieved from a second external service provider API according to the context parameter.
I did a pet scan to check an enlarged thymus gland post thyroid cancer. Results I got today say diffuse thymic FDG activity with SUV max of 2.9. What does this mean? Should cancer be suspected?
Not the best news but at least you have options available still. I do not think you were her when Jana was here. She was one of the greatest people that I never had the pleasure of meeting but boy could she come up with a statement that would stop me in my tracks. We would email each other from time to time and once i was complaining about the side effects of something or about a surgery and all she has to say was "at least you have options open, I have none". She passed away maybe a year ago or so but she was right. Having options is 100% better than having no options. You and I are in similar boats Eric, Im not getting cured anytime soon if I am at all. Yours is more urgent though but its not a contest. My point? You have options. Maybe your Onc doesnt want to use them now but if not now, when? Hes got the right idea I think, its often about buying time until the next thing comes along.. Im surprised that the erbitux didnt level off. I have been on that stuff over 3 years, Im back on ...
Not the best news but at least you have options available still. I do not think you were her when Jana was here. She was one of the greatest people that I never had the pleasure of meeting but boy could she come up with a statement that would stop me in my tracks. We would email each other from time to time and once i was complaining about the side effects of something or about a surgery and all she has to say was "at least you have options open, I have none". She passed away maybe a year ago or so but she was right. Having options is 100% better than having no options. You and I are in similar boats Eric, Im not getting cured anytime soon if I am at all. Yours is more urgent though but its not a contest. My point? You have options. Maybe your Onc doesnt want to use them now but if not now, when? Hes got the right idea I think, its often about buying time until the next thing comes along.. Im surprised that the erbitux didnt level off. I have been on that stuff over 3 years, Im back on ...
Acute Myeloid Leukemia is an extremely difficult cancer to treat but recently a better understanding of this stubborn disease and advancements in treating it have brought more hope and a renewed feeling of optimism to the Acute Myeloid Leukemia community. Guest Dr. Jessica Altman brings us up to speed on the new treatments and new approaches to treating AML.. For more information on AML, visit out AML resource page.. ...
my husband went in and got blood work done and his liver tests were high so he went in to be retested over a month later and they r still high. I would like to know what they mean. his alt is 48 his as...
Last July, Dr. Amy took the month off from reviewing test results to write out all of her innovative ways of interpreting and responding to your test result data. This was done in an effort to make her work accessible to more people. The project took a leap forward in the past few weeks when…
The existence or absence of the chance variable is assessed for the period quickly ahead of the individual seasoned the outcome. This is certainly in comparison Along with the existence or absence of the risk element when the person did not knowledge the outcome (Command time period). If there is a connection in between the danger element and the end result, it would be predicted to happen to be present from the period just before the end result extra generally than in the Management period ...
This trial assessed the efficacy and safety of sorafenib in advanced hepatocellular carcinoma patients in SEER-Medicare Database. The study determined the
Disease Surveillance Epidemiology Programs primary purpose is to study the distribution and determinants of notifiable Disease Surveillances
According to the American Journal of Clinical Nutrition, which is published by The American Society for Nutrition, research conducted by the Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm (SCL and AW), and the Department of Surgery and the Center for Clinical Research, Uppsala University, Central Hospital, Västerås, Sweden (LB) found that women who consumed high intakes of four servings or more per day of dairy products (about 32 ounces of milk) had twice the risk of ovarian cancer than women who consumed less than two servings per day. According to the U.S. National Institute of Healths National Cancer Institutes Surveillance Epidemiology and End Results (SEER) report the ovarian cancer rate for women in 2003 was 13.2 per 100,000 (or 0.0132%). Thus, doubling ones risk would go from 0.0132% to 0.0264% (or a total increased risk of 13/1000 of a percent). Of course, this all assumes the 0.0132% was a baseline ovarian ...
BACKGROUND: Despite advancements in the treatment of childhood leukemia, socioeconomic status (SES) may potentially affect disease prognosis. This study aims to evaluate whether SES is associated with survival from childhood leukemia.. METHODS: The US National Cancer Institute Surveillance, Epidemiology and End Results Program (SEER) 1973-2010 data were analyzed; thereafter, results were meta-analyzed along with those from survival (cohort) studies examining the association between SES indices and survival from childhood leukemia (end-of-search date: 31 March 2014). Random-effects models were used to calculate pooled effect estimates (relative risks, RRs); meta-regression was also used.. RESULTS: We included 29 studies yielding 28 804 acute lymphoblastic leukemia (ALL), 3208 acute myeloblastic leukemia (AML) and 27 650 any leukemia (denoting joint reporting of all subtypes) cases. According to individual-level composite SES indices, children from low SES suffered from nearly twofold higher ...
Authors: Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA. Title: Hematopoietic malignancies associated with viral and alcoholic hepatitis.. Journal: Cancer Epidemiol Biomarkers Prev 17(11):3069-75. Date: 2008 Nov. Abstract: Hepatitis C virus (HCV) and hepatitis B virus (HBV) have been associated with hematopoietic malignancies, but data for many subtypes are limited. From the U.S. Surveillance, Epidemiology, and End Results-Medicare database, we selected 61,464 cases (> or = 67 years) with hematopoietic malignancies and 122,531 population-based controls, frequency-matched by gender, age, and year (1993--2002). Logistic regression was used to compare the prevalence of HCV, HBV, and alcoholic hepatitis in cases and controls, adjusted for matching factors, race, duration of Medicare coverage, and number of physician claims. HCV, HBV, and alcoholic hepatitis were reported in 195 (0.3%), 111 (0.2%), and 404 (0.7%) cases and 264 (0.2%), ...
Background: Non-Hodgkin lymphoma (NHL) comprises distinct tumor subtypes. Although mortality from NHL overall has changed dramatically in the United States over time, little is known about trends for subtypes, because death certificates do not record this information.. Methods: Using data from U.S. Surveillance, Epidemiology, and End Results (SEER) areas, we assessed NHL mortality rates and mapped NHL deaths to incident NHL cases in SEER cancer registries. This allowed us to evaluate population-level mortality trends attributed to specific NHL subtypes (incidence-based mortality; IBM). We also describe NHL incidence and survival after NHL diagnosis by calendar year. We used Joinpoint to identify years when IBM and incidence rate trends changed slope.. Results: Overall NHL mortality rates increased during 1975-1997, peaking at 10.9 per 100,000 person-years, then decreased subsequently in 1997-2011. Overall IBM rates mirror this trend during 1990-2011. For B-cell NHL subtypes, IBM rates decreased ...
Real-World Treatment Patterns and Outcomes among Elderly Acute Myeloid Leukemia Patients in the United States. By Sacha Satram- Hoang, Carolina Reyes, Deborah Hurst, Khang Q. Hoang and Bruno C. Medeiros. Over half of patients diagnosed with acute myeloid leukemia (AML) are 65 years or older. Using the linked SEER-Medicare database, we conducted a retrospective cohort analysis to examine patient characteristics, treatment patterns, and survival among the elderly AML patients in routine clinical practice. Out of 29,857 patients with AML in the database, 8336 were eligible for inclusion in the study. The inclusion criteria included a diagnosis with first primary AML between January 1, 2000 and December 31, 2009, ,66 years of age, and continuous enrollment in Medicare Parts A and B in the year before diagnosis. Forty percent (N = 3327) of the cohort received chemotherapy within 3 months after diagnosis. The multivariable overall survival analyses showed a lower risk of death among those receiving ...
A summary of the article is shown below:. OBJECTIVES: The incidence of depression after a late-stage cancer diagnosis is poorly understood and has not been the subject of intense investigation. We used population-based data to examine trends in postdiagnosis depression incidence among racial/ethnic and sexual groups.METHODS: We identified 123,066 patients diagnosed with late-stage breast, prostate, lung, or colorectal cancer from 2001 to 2013 in the Surveillance Epidemiology and End Results Medicare-linked database. The primary outcome was the incidence of postdiagnosis depression after a late-stage cancer diagnosis. Trend analysis was performed using the Cochran-Armitage test. Stratified incidence rates were calculated for the racial/ethnic and sexual groups.RESULTS: The incidence of depression after cancer diagnosis increased from 15.3% in 2001 to 24.1% in 2013, P ...
We hypothesized that breast cancer (BCa) patients in urban counties would have higher rates of post-lumpectomy radiation therapy (RT) relative to patients in near-metro and rural counties. We used the Surveillance, Epidemiology, and End Results (SEER) database to identify women diagnosed with BCa tr …
This phase II trial studies how well epacadostat and pembrolizumab work in treating patients with gastroesophageal junction or gastric cancer that has spread to other parts of the body and cannot be removed by surgery. Epacadostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Giving epacadostat and pembrolizumab may work better in treating patients with gastroesophageal junction or gastric cancer. Stanford is currently accepting patients for this trial.. ...
We know its a worrying time for people with cancer. Please read our information about coronavirus and cancer alongside this page. If you have symptoms of cancer you should still contact your doctor and go to any appointments you have. Spotting cancer early means treatment is more likely to be successful.. Read about coronavirus and cancer. ...
We know its a worrying time for people with cancer. Please read our information about coronavirus and cancer alongside this page. If you have symptoms of cancer you should still contact your doctor and go to any appointments you have. Spotting cancer early means treatment is more likely to be successful.. Read about coronavirus and cancer. ...
A Pap smear every two years offers the best chance of preventing cervical cancer. Read our fact sheet on symptoms, screening and risk.
The aim of the present study was to examine the epidemiology, natural history, treatment and long-term survival of patients with adenosquamous cell carcinoma of the prostate. The Surveillance, Epidemiology, and End Results (SEER) Program database was used ...
56 Cancers originate due to the accumulation of multiple mutations. The mechanism causing this, particularly in the case of epithelial cancers, or carcinomas, has not been clearly determined. Epidemiological studies indicate that environmental and lifestyle factors can account for most carcinomas, but do not point to a specific mechanism. Some models for human carcinogenesis suggest that the accumulation of four to six somatic mutations drives the neoplastic transformation. The number of mutations, four to six, is based almost exclusively on the analysis of age-specific incidence data. Several anomalies exist with the age-specific incidence data. For instance, breast carcinoma incidence data does not follow this model. (This has been explained by suggesting that breast tissue ages at a different rate than calendar time.) Prostate carcinoma incidence increases more rapidly with age than most others, implying that 15 to 20 mutations are required. Hence, one approach to better understand epithelial ...
Over the years, the age-adjusted incidence rate due to invasive cancer has continued to decline for NJ males but has remained fairly steady for NJ females. In the total NJ population and among each racial/ethnic group, males have higher incidence rates compared to females. The age-adjusted incidence rate of total invasive cancer among NJ Black males, which has historically ranked highest for decades, is now trending below White males in recent years. For recent years, county incidence rates range from a low of 389 per 100,000 population in Hudson County to a high of 544 per 100,000 population in Gloucester County ...
The end result of mitosis is two identical daughter cells. These daughter cells are also identical to the parent cell. Mitosis is essential for growth and repair in living...
comorbidity definition: the clear presence of several conditions (or conditions) as well as a primary illness or condition.; the end result of these extra problems or conditions.; The presence of more…
Most cancers dont develop overnight or out of nowhere,It develop base on our lifestyle,what we drink,what we eat,what we do in our health,what we take.cancer is highly predictable, the end result of a decade-long process,but just a few simple changes in your daily life can significan ...
Abstract - Objective: The purpose of this paper is to describe the extent of the public health problem presented by palatine tonsillar cancer in the United States by analyzing recent incidence and mortality rate trends.. Methods: Using the National Cancer Institutes Surveillance, Epidemiology and End Results (SEER) Program database, age-adjusted incidence rates (1973-2001) for five histological types of palatine tonsillar cancer by race and sex were calculated. For total palatine tonsillar cancer age-specific incidence (1973-2001) and mortality (1969-2001) rates by race and sex were calculated. Mortality and population data were obtained from the National Center for Health Statistics (NCHS) and the U.S. Census Bureau. The Joinpoint Regression Model was employed to establish the statistical significance of incidence and mortality rate trends.. Results: The majority of palatine tonsillar cases diagnosed in SEER-9 registries from 1973 to 2001 occurred among white males, age 40-64 years, with ...